UK-based developer of 3G femtocells solution, Ubiquisys announced the completion of its second series of fund raising exercise valued at $ 5 million with Taiwanese companies SerComm Corporation, UMC Capital Corporation and Pacific Venture Partners participating in the investment along with existing investors Advent Venture Partners, Accel Partners and Atlas Venture. 

"Asia plays a leading role in the femtocell industry today, both in terms of product diversity and business model innovation," said Chris Gilbert, CEO Ubiquisys. "Our work with SoftBank and SerComm has broken new ground and we are delighted to be adding strategic investors who bring extra know-how to help Ubiquisys build on our strong international momentum."